BRTX Financials
BioRestorative Therapies Inc - Financial statements & key metrics
Stock Price
$0.20
Market Cap
$10.18M
P/E Ratio
-0.2
EPS
$-1.46
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$401,000
Gross Profit
-
Operating Income
-
Net Income
$-8.98M
EPS (Diluted)
$-1.16
Balance Sheet Highlights
Total Assets
$12.28M
Total Liabilities
$3.75M
Shareholders Equity
-
Cash & Equivalents
$547,890
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-8.23M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-31432.3%
ROE
-207.7%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is BRTX revenue?
BRTX's most recent quarterly revenue was $401,000. Annual revenue can be calculated by summing the four most recent quarters.
Is BRTX profitable?
BRTX reported a loss of $8.98M in the most recent quarter.
What is BRTX market cap?
BRTX has a market capitalization of $10.18M, making it a small-cap stock.
Does BRTX have debt?
View BRTX's balance sheet for debt information.
What is BRTX cash flow?
Cash flow data is available in the full financial statements.